Aktive Positionen von Amy Conrad
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TYRA BIOSCIENCES, INC. | Investor Relations Kontakt | - | - |
| Public Communications Contact | - | - | |
| Juniper Point, Inc. | Vorstandsvorsitzender | - | - |
Karriereverlauf von Amy Conrad
Ehemalige bekannte Positionen von Amy Conrad
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| REGULUS THERAPEUTICS INC. | Investor Relations Kontakt | - | 01.01.2016 |
| Public Communications Contact | - | 01.01.2016 | |
| BIONANO GENOMICS, INC. | Investor Relations Kontakt | - | - |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Investor Relations Kontakt | 23.08.2011 | - |
| Public Communications Contact | 26.05.2010 | - |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Investor Relations Contact | 4 |
| Public Communications Contact | 3 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 5 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| REGULUS THERAPEUTICS INC. | Health Technology |
| BIONANO GENOMICS, INC. | Health Technology |
| TYRA BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Health Technology |
| Juniper Point, Inc. |
- Börse
- Insiders
- Amy Conrad
- Erfahrung
